Definitive Contract W81XWH22C0073
Award Date
7/11/22
Potential Completion Date
11/10/24
Potential Value
$1.1M
Federal Agency
Medical Command
Awardee
Zymeron Corporation
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This contract is a $249,999.09 Small Business Innovation Research (SBIR) Phase I award from the Department of the Army Medical Command to Zymeron Corporation, a minority-owned biotechnology company based in Research Triangle Park, North Carolina. The award supports the research and development of a "Novel Antibiotic Targeting Multidrug-Resistant Pseudomonas Aeruginosa Infections." As a prime contractor, Zymeron has experience providing medical research, engineering services, IT...
This is a firm-fixed-price purchase order contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Zymeron Corporation, a minority-owned, for-profit biotechnology company, under the Small Business Innovation Research (SBIR) Program Phase I. The contract, valued at $197,000.00, is for research and development services related to an unspecified biomedical or public health initiative. As a total small business set-aside, this award aligns with Zymeron's...
This contract was awarded by the Department of the Army Materiel Command TACOM Life Cycle Management Command to Zymeron Corporation, a minority-owned small business. The contract is for Phase I SBIR (Small Business Innovation Research) research, with a firm fixed-price contract type and a potential value of $162,482.83. Zymeron is a biotechnology company that focuses on developing innovative technologies in areas such as protein degradation, antibacterials, antivirals, and drug delivery systems....
This is a firm fixed-price purchase order awarded to Zymeron Corporation, a minority-owned small business, under the Department of the Army Medical Command's Small Business Innovation Research (SBIR) program. The $250,000.00 Phase I contract is for the research and development of a "Novel Aerosol Therapy for Immediate and Sustained ARDS Management". Zymeron, a biotechnology company focused on areas like drug delivery systems, will perform this medical research at its facilities in...
This is a $167,489.14 firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Zymeron Corporation, a minority-owned small business, under the Army's SBIR (Small Business Innovation Research) Phase I program. The contract is for the development of "Rapid Point of Care Diagnostic Tests to Determine Dengue Serostatus", which aims to create a point-of-care test to assess past exposure to the dengue virus. The contract has a completion date of January 2, 2021....
This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Zymeron Corporation, a Minority Owned small business, under the Small Business Innovation Research (SBIR) Program. The objective is to develop a new chemical entity drug for proteolytic degradation of HIV Gag proteins. The contract is a Firm Fixed Price Definitive Contract with a potential value of $299,794.00 and a...
The Defense Health Agency (DHA) awarded a Small Business Technology Transfer (STTR) Phase I contract to Zymeron Corporation, a minority-owned biotechnology company, for the "Development of WoundShield for Pseudomonas aeruginosa-caused Wound Infections". This $249,995.45 firm-fixed-price purchase order will support research and development efforts to advance this novel medical solution. As the prime contractor, Zymeron will perform the work at its facility in Research Triangle Park,...
This is a $224,999 firm fixed-price contract awarded to Zymeron Corporation, a minority-owned small business, by the Defense Advanced Research Projects Agency (DARPA) under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of a lab-on-chip microfiltering and imaging device for rapid and automated sterility testing. This effort aligns with DARPA's mission to provide game-changing capabilities to the warfighter and its focus on leveraging small...
This is a $222,693 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services. The prime contractor is Zymeron Corporation, a minority-owned small business biotechnology company based in North Carolina. Under this contract, Zymeron will investigate the use of lateral flow immunoassays to rapidly determine the serostatus of individuals for cytomegalovirus (CMV) infections. The...
This is a federal contract award from the U.S. Army Medical Command (MEDCOM) to Qrono, Inc., a small business. The contract is a Small Business Innovation Research (SBIR) Phase I award valued at $149,927.50 with a firm fixed price. The contract was awarded on September 15, 2015 and has an ultimate completion date of July 31, 2017. The contract is focused on medical and scientific research and development, with Qrono, Inc. specializing in innovative drug delivery systems and immunotherapy...